These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 31982432)
1. Chitosan nanoparticles as a delivery platform for neurotoxin II from Androctonus australis hector scorpion venom: Assessment of toxicity and immunogenicity. Rebbouh F; Martin-Eauclaire MF; Laraba-Djebari F Acta Trop; 2020 May; 205():105353. PubMed ID: 31982432 [TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a new carrier for vaccine delivery based on calcium-alginate nanoparticles: Safe immunoprotective approach against scorpion envenoming. Nait Mohamed FA; Laraba-Djebari F Vaccine; 2016 May; 34(24):2692-9. PubMed ID: 27109567 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the immunoprotective power of a multiple antigenic peptide against Aah II toxin of Benazzouz SM; Benlouahmia N; Bouhadida K; Benlamara M; Arezki N; Sadeddine OEK; Issad M; Attal N; Mansouri K; Derrar F; Djidjik R Vaccine X; 2024 Aug; 19():100503. PubMed ID: 38868522 [TBL] [Abstract][Full Text] [Related]
4. Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins. Meddeb-Mouelhi F; Bouhaouala-Zahar B; Benlasfar Z; Hammadi M; Mejri T; Moslah M; Karoui H; Khorchani T; El Ayeb M Toxicon; 2003 Dec; 42(7):785-91. PubMed ID: 14757210 [TBL] [Abstract][Full Text] [Related]
5. Immunomodulation of the inflammatory response induced by Androctonus australis hector neurotoxins: biomarker interactions. Raouraoua-Boukari R; Sami-Merah S; Hammoudi-Triki D; Martin-Eauclaire MF; Laraba-Djebari F Neuroimmunomodulation; 2012; 19(2):103-10. PubMed ID: 22248726 [TBL] [Abstract][Full Text] [Related]
6. New and safe formulation for scorpion immunotherapy: Comparative study between saponin and FCA adjuvants associated to attenuated venom. Nouri A; Nait Mohamed FA; Laraba-Djebari F Vaccine; 2018 Mar; 36(13):1720-1727. PubMed ID: 29483031 [TBL] [Abstract][Full Text] [Related]
7. Venom conjugated polylactide applied as biocompatible material for passive and active immunotherapy against scorpion envenomation. Ayari-Riabi S; Trimaille T; Mabrouk K; Bertin D; Gigmes D; Benlasfar Z; Zaghmi A; Bouhaouala-Zahar B; Elayeb M Vaccine; 2016 Apr; 34(15):1810-5. PubMed ID: 26902547 [TBL] [Abstract][Full Text] [Related]
8. Immunological characterization of a non-toxic peptide conferring protection against the toxic fraction (AahG50) of the Androctonus australis hector venom. Srairi-Abid N; Kaabi H; Mlayah-Bellalouna S; Mejri T; Sampieri F; El Ayeb M Toxicon; 2008 Mar; 51(3):353-62. PubMed ID: 18054371 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of long-lasting immunoprotective effect against Androctonus australis hector envenomation using safe antigens: Comparative role of MF59 and Alum adjuvants. Nouri A; Laraba-Djebari F Vaccine; 2015 Oct; 33(43):5756-5763. PubMed ID: 26419199 [TBL] [Abstract][Full Text] [Related]
10. Development of a new approach of immunotherapy against scorpion envenoming: Avian IgYs an alternative to equine IgGs. Sifi A; Adi-Bessalem S; Laraba-Djebari F Int Immunopharmacol; 2018 Aug; 61():256-265. PubMed ID: 29902709 [TBL] [Abstract][Full Text] [Related]
11. Use of fusion protein constructs to generate potent immunotherapy and protection against scorpion toxins. Legros C; Kaabi H; El Ayeb M; Céard B; Vacher H; Bougis PE; Martin-Eauclaire MF Vaccine; 2001 Dec; 20(5-6):934-42. PubMed ID: 11738760 [TBL] [Abstract][Full Text] [Related]
12. The amino acid sequence of toxin IV from the Androctonus australis scorpion: differing effects of natural mutations in scorpion alpha-toxins on their antigenic and toxic properties. Mansuelle P; Martin MF; Rochat H; Granier C Nat Toxins; 1992; 1(1):61-9. PubMed ID: 1344902 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies against the Androctonus australis hector scorpion neurotoxin I: characterisation and use for venom neutralisation. Clot-Faybesse O; Juin M; Rochat H; Devaux C FEBS Lett; 1999 Sep; 458(3):313-8. PubMed ID: 10570931 [TBL] [Abstract][Full Text] [Related]
14. In vivo protection against Androctonus australis hector scorpion toxin and venom by immunization with a synthetic analog of toxin II. Zenouaki I; Kharrat R; Sabatier JM; Devaux C; Karoui H; Van Rietschoten J; el Ayeb M; Rochat H Vaccine; 1997 Feb; 15(2):187-94. PubMed ID: 9066037 [TBL] [Abstract][Full Text] [Related]
15. Enhanced immune sera and vaccine: safe approach to treat scorpion envenoming. Lila BA; Laraba-Djebari F Vaccine; 2011 Nov; 29(48):8951-9. PubMed ID: 21945260 [TBL] [Abstract][Full Text] [Related]
16. Fine molecular analysis of the antigenicity of the Androctonus australis hector scorpion neurotoxin II: a new antigenic epitope disclosed by the Pepscan method. Devaux C; Juin M; Mansuelle P; Granier C Mol Immunol; 1993 Aug; 30(12):1061-8. PubMed ID: 7690110 [TBL] [Abstract][Full Text] [Related]
17. Two-dimensional 1H nuclear magnetic resonance study of AaH IT, an anti-insect toxin from the scorpion Androctonus australis Hector. Sequential resonance assignments and folding of the polypeptide chain. Darbon H; Weber C; Braun W Biochemistry; 1991 Feb; 30(7):1836-45. PubMed ID: 1993198 [TBL] [Abstract][Full Text] [Related]
18. Age-Related Changes in Inflammatory Response after Experimental Envenomation: Impact on the Susceptibility to Androctonus australis hector Venom. Haddad-Ishak-Boushaki W; Laraba-Djebari F Inflammation; 2017 Aug; 40(4):1131-1142. PubMed ID: 28405853 [TBL] [Abstract][Full Text] [Related]
19. Effects of toxin II from the scorpion Androctonus australis Hector on sodium current in neuroblastoma cells and their modulation by oleic acid. Jourdon P; Berwald-Netter Y; Houzet E; Couraud F; Dubois JM Eur Biophys J; 1989; 16(6):351-6. PubMed ID: 2538322 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the effect of the scorpion toxin AaH-II on action potential generation in the axon initial segment. Abbas F; Blömer LA; Millet H; Montnach J; De Waard M; Canepari M Sci Rep; 2024 Feb; 14(1):4967. PubMed ID: 38424206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]